Lyndra Therapeutics

About:

Lyndra Therepeutics creates therapies for long-term drug release in an oral dose form.

Website: https://www.lyndra.com

Twitter/X: LyndraInc

Top Investors: Gilead Sciences, Invus, Bill & Melinda Gates Foundation, Polaris Partners, Fujifilm

Description:

Lyndra Therapeutics is a company that develops medicines for long-term drug release in an oral dose form. The company is developing oral ultra-long-acting and sustained-release therapies for central nervous system (CNS) disorders for broad applicability across multiple therapeutic areas, including approved drugs, allowing the medical community to ensure improved medication adherence and health outcomes while also helping to lower healthcare costs.

Total Funding Amount:

$285M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Watertown, Massachusetts, United States

Founded Date:

2015-01-14

Contact Email:

info(AT)lyndra.com

Founders:

Amy Schulman, Andrew Bellinger, Colin R. Gardner, Giovanni Traverso

Number of Employees:

101-250

Last Funding Date:

2023-12-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai